Gus Schepens

Gus Schepens is an accomplished professional in the pharmaceutical industry with a strong background in new product planning, commercial development, and global marketing.

Gus Schepens received his education from Brown University and the Questrom School of Business at Boston University, showing his commitment to academic excellence.

Currently, Gus Schepens holds the position of Executive Director at Ulotaront (SEP-856) Worldwide GM at Sunovion Pharmaceuticals, showcasing his leadership skills and strategic vision.

With a remarkable career progression, Gus Schepens has held various key roles at Sunovion Pharmaceuticals, including Senior Director and Director in New Products Planning, as well as in commercial development and marketing.

Prior to his tenure at Sunovion Pharmaceuticals, Gus Schepens enriched his experience as Associate Director at the Global R&D Office at Dainippon Sumitomo Pharma and held marketing and planning positions at Forest Laboratories.

Gus Schepens' diverse experience in pharmaceutical leadership roles underscores his expertise in driving successful new product launches and strategic marketing initiatives.

Through his professional journey, Gus Schepens has demonstrated a deep understanding of the pharmaceutical industry and a keen ability to navigate complex global markets with innovation and business acumen.